Filter
481
Text search:
Emergency
Use
Authorization
Featured
Recommendations
51
New Publications
112
Language
Document type
No document type
206
Guidelines
107
Studies & Reports
79
Manuals
30
Strategic & Response Plan
22
Fact sheets
22
Training Material
10
Situation Updates
3
Resource Platforms
2
Countries / Regions
India
18
Kenya
18
Myanmar / Burma
15
Global
14
Latin America and the Carribbean
11
Nigeria
10
Africa
9
Sierra Leone
8
Liberia
8
Ghana
8
Western and Central Europe
8
Syria
7
Rwanda
7
Bangladesh
7
Haiti
6
Nepal
6
Malawi
6
East and Southern Africa
6
West and Central Africa
6
Congo, Democratic Republic of
5
South Sudan
5
South Africa
5
Senegal
4
Ethiopia
4
Cameroon
4
Uganda
4
Zimbabwe
4
Germany
4
Tanzania
4
Brazil
4
Middle East and North Africa
4
Eastern Europe and Central Asia
4
Guinea
3
Philippines
3
Cambodia
3
Eswatini/ Swaziland
3
Ecuador
3
Yemen
3
Venezuela
3
Russia
3
Mali
2
Pakistan
2
Afghanistan
2
Thailand
2
Namibia
2
Colombia
2
Lesotho
2
South–East Asia Region
2
Eastern Europe
2
Côte d’Ivoire / Ivory Coast
1
USA
1
Iraq
1
Zambia
1
Chad
1
Gambia
1
Indonesia
1
Peru
1
North Macedonia
1
Serbia
1
Ukraine
1
Bolivia
1
Libya
1
Chile
1
Paraguay
1
Asia
1
Palestine
1
Albania
1
Armenia
1
Laos
1
Tajikistan
1
Uzbekistan
1
Kyrgyzstan
1
Kazakhstan
1
Georgia
1
Vietnam
1
Maldives
1
Spain
1
Authors & Publishers
Publication Years
Category
Countries
172
Key Resources
37
Clinical Guidelines
34
Women & Child Health
24
Public Health
17
Pharmacy & Technologies
12
Capacity Building
3
Toolboxes
COVID-19
125
Pharmacy
23
Rapid Response
22
Ebola & Marburg
21
HIV
19
Conflict
14
AMR
13
2.0 Rapid Response
11
TB
10
Planetary Health
10
Natural Hazards
9
Mental Health
9
Refugee
8
Specific Hazards
7
Global Health Education
6
Caregiver
6
Malaria
6
Zika
5
Health Financing Toolbox
5
Cholera
3
NTDs
3
Disability
2
NCDs
2
Polio
1
Social Ethics
1
10 May 2021. Manufactureres:
SK Bioscience Co. Ltd. [COVID-19 Vaccine (ChAdOx1-S [recombinant])]
Serum Institute of India Pvt. Ltd. [COVISHIELD™, ChAdOx1 nCoV-19 Corona Virus Vaccine (Recombinant)]
The ChAdOx1-S/nCoV-19 [recombinant] vaccine is a replication-deficient adenoviral vecto
...
This document provides brief information answering common questions regarding COVID-19 diagnostic tests and how to prioritize them to the patients most in need.
Cholera is a diarrhoeal disease that is usually contracted when drinking water contaminated with Vibrio cholerae bacteria. The fight against this disease requires a multidisciplinary approach that combines a water, hygiene and sanitation (WaSH) response with a monitoring system, improved water suppl
...
Mpox can spread in humans through close contact, usually skin-to-skin contact, including sexual contact, with an infected person or animal, as well as with materials contaminated with the virus such as clothing, beddings and towels, and respiratory droplets in prolonged face to face contact. People
...
an approach to optimize the global impact of COVID-19 vaccines, based on public health goals, global and national equity, and vaccine access and coverage scenarios, first issued 20 October 2020, updated: 13 November 2020, updated: 16 July 2021, latest update: 21 January 2022
Available in English, F
...
COVID-19 Vaccines: 1 Safety Surveillance 2 Manual
While there is no indication that pregnant women have an increased susceptibility to infection with SARS-CoV-2, there is evidence that pregnancy may increase the risk of severe illness and mortality from COVID-19 disease in comparison with non-pregn
...
This document provides answers to FAQs healthcare providers and staff may have about COVID-19 vaccines
Climate change triggers mounting food insecurity, poverty and displacement in Africa
These guidelines are applicable to all biomedical, social and behavioural science research for health conducted in India involving human participants, their biological material and data.
The purpose of such research should be: i. directed towards enhancing knowledge about the human condition while
...
Guiding Principles and Recommendations
